To Compare the Efficacy and Safety of HRS9531 and Placebo in Subjects With Overweight or Obese

NCT06396429 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

567

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight or Obesity

Interventions

DRUG: HRS9531 injection
DRUG: HRS9531 injection
DRUG: HRS9531 injection
DRUG: Placebo

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.